Market Tracker

03/24 5:16pm ET

Emergent BioSolutions Inc (NYSE:EBS)

28.82
Delayed Data
As of Mar 24
 +0.46 / +1.62%
Today’s Change
24.47
Today|||52-Week Range
41.91
-12.24%
Year-to-Date
No recent news for Emergent BioSolutions Inc.

Today’s Trading

Previous close28.36
Today’s open28.47
Day’s range28.06 - 29.06
Volume386,383
Average volume (3 months)438,599
Market cap$1.2B
Dividend yield--
Data as of 4:02pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-19.86%
Earnings growth (this year)-0.56%
Earnings growth (next 5 years)+22.00%
Revenue growth (last year)-6.50%
P/E ratio21.3
Price/Sales3.31
Price/Book1.96

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp-0.07-0.20%
ACORAcorda Therapeutics ...0.000.00%
LOXOLoxo Oncology Inc+1.01+2.27%
AIMTAimmune Therapeutics...+0.04+0.18%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)$0.30
Annual revenue (last year)$488.8M
Annual profit (last year)$51.8M
Net profit margin12.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class III Director
Daniel J. Abdun-Nabi
CFO, Treasurer &
EVP-Corporate Services
Robert G. Kramer
Corporate headquarters
Gaithersburg, Maryland

Forecasts